Research Bridge Partners Makes Seed Capital Investment in Eradivir, Inc.

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

"The scientific team has a proven track record of building commercially successful targeting ligands, including Endocyte, which Novartis purchased in 2018 for $2.1 billion," said Isaac Barchas, co-founder and CEO of Research Bridge Partners.